These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

157 related items for PubMed ID: 1280097

  • 1. Overview of low molecular weight heparins and heparinoids: basic and clinical aspects.
    Hirsh J.
    Aust N Z J Med; 1992 Oct; 22(5):487-95. PubMed ID: 1280097
    [Abstract] [Full Text] [Related]

  • 2. Successors to heparin: new antithrombotic agents.
    Turpie AG.
    Am Heart J; 1997 Nov; 134(5 Pt 2):S71-7. PubMed ID: 9396637
    [Abstract] [Full Text] [Related]

  • 3. From unfractionated heparins to low molecular weight heparins.
    Hirsh J.
    Acta Chir Scand Suppl; 1990 Nov; 556():42-50. PubMed ID: 1705072
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Low molecular weight heparin: a critical analysis of clinical trials.
    Green D, Hirsh J, Heit J, Prins M, Davidson B, Lensing AW.
    Pharmacol Rev; 1994 Mar; 46(1):89-109. PubMed ID: 8190751
    [Abstract] [Full Text] [Related]

  • 7. Perspectives on antithrombotic agents: from unfractionated heparin to new antithrombotics.
    Agnelli G, Sonaglia F.
    Haematologica; 2002 Jul; 87(7):757-70. PubMed ID: 12091128
    [Abstract] [Full Text] [Related]

  • 8. Low-molecular-weight heparin in the treatment of deep venous thrombosis.
    Hauer KE.
    West J Med; 1998 Oct; 169(4):240-4. PubMed ID: 9795594
    [Abstract] [Full Text] [Related]

  • 9. Low molecular weight heparin for the out-of-hospital treatment of venous thrombosis: rationale and clinical results.
    Hirsh J, Crowther M.
    Thromb Haemost; 1997 Jul; 78(1):689-92. PubMed ID: 9198240
    [Abstract] [Full Text] [Related]

  • 10. [Low molecular weight heparin].
    Pini M.
    Recenti Prog Med; 1997 Dec; 88(12):594-602. PubMed ID: 9522605
    [Abstract] [Full Text] [Related]

  • 11. The use of antithrombotic drugs in older people.
    Tufano A, Cerbone AM, Di Minno G.
    Minerva Med; 2002 Feb; 93(1):13-26. PubMed ID: 11850611
    [Abstract] [Full Text] [Related]

  • 12. [State of the art: low-molecular-weight heparin and beyond].
    Cimminiello C, Casali G, Vitali L.
    Minerva Cardioangiol; 2000 Dec; 48(12 Suppl 1):61-5. PubMed ID: 11253343
    [Abstract] [Full Text] [Related]

  • 13. [Practical use of low molecular weight heparins in angiology].
    Plettner JL.
    J Mal Vasc; 1991 Dec; 16(4):398-401. PubMed ID: 1665170
    [Abstract] [Full Text] [Related]

  • 14. Are all low molecular weight heparins equivalent in the management of venous thromboembolism?
    Fareed J, Jeske W, Fareed D, Clark M, Wahi R, Adiguzel C, Hoppensteadt D.
    Clin Appl Thromb Hemost; 2008 Oct; 14(4):385-92. PubMed ID: 18815137
    [Abstract] [Full Text] [Related]

  • 15. Should low-molecular-weight heparins replace unfractionated heparin as the agent of choice for adults with deep venous thrombosis?
    Brewer D.
    J Fam Pract; 1998 Sep; 47(3):185-92. PubMed ID: 9752370
    [Abstract] [Full Text] [Related]

  • 16. Treatment of deep vein thrombosis using low-molecular-weight heparins.
    Groce JB.
    Am J Manag Care; 2001 Nov; 7(17 Suppl):S510-5; discussion S515-23. PubMed ID: 11732662
    [Abstract] [Full Text] [Related]

  • 17. Low-molecular-weight heparin therapy and mortality.
    Valentine KA, Hull RD, Pineo GF.
    Semin Thromb Hemost; 1997 Nov; 23(2):173-8. PubMed ID: 9200343
    [Abstract] [Full Text] [Related]

  • 18. Low molecular weight heparins in the initial treatment of deep vein thrombosis.
    Volteas SK, Kalodiki E, Nicolaides AN.
    Int Angiol; 1996 Mar; 15(1):67-74. PubMed ID: 8739540
    [Abstract] [Full Text] [Related]

  • 19. [Low molecular weight heparins].
    Kher A, Bara L, Samama M.
    Pathol Biol (Paris); 1986 Jan; 34(1):61-9. PubMed ID: 3517772
    [Abstract] [Full Text] [Related]

  • 20. Ex-vivo and in-vitro evidence that low molecular weight heparins exhibit less binding to plasma proteins than unfractionated heparin.
    Young E, Wells P, Holloway S, Weitz J, Hirsh J.
    Thromb Haemost; 1994 Mar; 71(3):300-4. PubMed ID: 8029793
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.